The real cause for optimism, Miller said, was in the second half of the FDA’s letter, which stated the agency’s intentions to hold public meetings and create a framework for federally regulating CBD products.

“We see a path in the very near future that the FDA will be formally approving of these products to be sold alongside the vitamin C’s and D’s and melatonins of the world,” said Miller.

📬 Sign up for the Daily Brief

Our free, fast, and fun briefing on the global economy, delivered every weekday morning.